|
|
Article: Instrument Index Stays Strong Despite Mixed First Quarter Results.(Brief Article)
- Article from:
- Instrument Business Outlook
- Article date:
- June 15, 2000
CopyrightCOPYRIGHT 2000 Strategic Directions International Inc. (SDI). This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
In the May 15th issue of IBO, calendar first quarter revenues for 16 of the 23 companies in the Laboratory Instrument Sales Index rose 18% over the same period of the prior year. As stated in that issue, the strong figures for the first quarter 2000 were not sufficient to predict how the index would perform as large companies, such as Agilent and Amersham Pharmacia Biotech, had not reported at that time. Now that almost all of the companies in the index have released their first quarter results, the first quarter revenue performance has changed. Agilent's Chemical Analysis Group (CAG), which comprises over 10% of the index, saw flat revenue growth. This caused index ...